[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343305-105":59,"doc-detail-343305-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","age-and-ethnic-driven-molecular-and-clinical-disparity-of-east-asian-breast-cancers","Age-and ethnic-driven molecular and clinical disparity of East Asian breast cancers","","Age- and ethnicity-related molecular differences in East Asian breast cancer remain insufficiently clarified, despite breast cancer being a complex disease driven by extensive genomic aberrations. This study analyzes 843 primary and metastatic patients from the K-MASTER program, stratified into two age groups, and integrates large-scale genomic datasets from TCGA and MSK-IMPACT to evaluate ethnic-driven molecular and clinical disparities. Findings identify distinct mutation patterns and a model for predicting platinum chemotherapy response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/age-and-ethnic-driven-molecular-and-clinical-disparity-of-east-asian-breast-cancers/343305/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/age-and-ethnic-driven-molecular-and-clinical-disparity-of-east-asian-breast-cancers/343305.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on East Asian breast cancers?","Question",{"text":112,"@type":113},"To determine how age and ethnicity influence molecular properties and clinical disparities in East Asian breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients analyzed in this research?",{"text":117,"@type":113},"The study investigated 843 primary and metastatic patients from the K-MASTER program, stratifying them into two age subgroups, and compared findings with large-scale genomic data from TCGA and MSK-IMPACT.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular features were highlighted as differing across groups?",{"text":121,"@type":113},"The study reports a high prevalence of PI3KCA mutations in K-MASTER HER2+ tumors, particularly in older patients, and identifies increased mutation rates in DNA damage response genes including ARID1A, MSH6, and MLH1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343305,1790202218,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Lee et al. BMC Medicine (2024) 22:422 [https://doi.org/10.1186/s12916-024-03638-y](https://doi.org/10.1186/s12916-024-03638-y)  \nBMC Medicine  \n RESEARCH Open Access  \nAge-and ethnic-driven molecular and clinical disparity of East Asian breast cancers  \nJi Yoon Lee1,2†, Ji Won Lee3†, Min Sung Chung4, Jong Gwon Choi5, Sung Hoon Sim6, Hyo Jeong Kim7, Jeong Eun Kim8, Kyoung Eun Lee9, Yeon Hee Park10, Myoung Joo Kang11, Mi Sun Ahn12, Yee Soo Chae13, Ji Hyun Park14, Jee Hyun Kim15, Gun Min Kim16, Jae Ho Byun17, Keon Uk Park18, Ju Won Kim3, Seung Pil Jung19, Jung Hyun Lee20, Jung Seok An20, Byunghyun Jang1,2, Dayoung Yoon1,2,21, Jiwon Kim1,2, Jisoo Hong1,2, Harim Koo1,2,22, Kyu Ran Cho23, Cheol Yong Kim23, Jason K. Sa 1,2* and Kyong Hwa Park3*  \nAbstract  \nBackground Breast cancer (BC) is a complex disease with profound genomic aberrations. However, the underlying molecular disparity influenced by age and ethnicity remains elusive.  \nMethods In this study, we aimed to investigate the molecular properties of 843 primary and metastatic BC patients enrolled in the K-MASTER program. By categorizing patients into two distinct age subgroups, we explored their unique molecular properties. Additionally, we leveraged large-scale genomic data from the TCGA and MSK-IMPACT studies to examine the ethnic-driven molecular and clinical disparities.  \nResults We observed a high prevalence of PI3KCA mutations in K-MASTER HER2 +tumors, particularly in older patients. Moreover, we identified increased mutation rates in DNA damage response molecules, including ARID1A, MSH6, and MLH1 . The K-MASTER patients were mainly comprised of triple-negative breast cancer (TNBC) and HER2-positive tumors, while the TCGA and MSK-IMPACT cohorts exhibited a predominance of hormone receptor-positive (HR +) subtype tumors. Importantly, GATA3 mutations were less frequently observed in East Asian patients, which correlated with poor clinical outcomes. In addition to characterizing the molecular disparities, we developed a gradient-boosting multivariable model to identify a new molecular signature that could predict the therapeutic response to platinum-based chemotherapy.  \nConclusions Our findings collectively provide unprecedented insights into the significance of age and ethnicity on the molecular and clinical characteristics of BC patients.  \nKeywords Breast cancer, Ethnic diversity, Genomic alterations, Molecular subtypes, Precision medicine  \n†Ji Yoon Lee and Ji Won Lee contributed equally to this work.  \n*Correspondence: Jason K. Sa [jasonksa@korea.ac.kr](jasonksa@korea.ac.kr)[ ](jasonksa@korea.ac.kr)Kyong Hwa Park [khpark@korea.ac.kr](khpark@korea.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nLee et al. BMC Medicine (2024) 22:422  \nBackground  \nBreast cancer (BC) is one of the most prevalent malignancies, accounting for one-quarter of all cancer diagnoses in women, resulting in an estimated 680,000 deaths worldwide each year [1]. BC can be classified into distinct subtypes based","cbCaivTj4i0i4DWn","https://ap.wps.com/l/cbCaivTj4i0i4DWn","pdf",3485863,15,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is the main goal of the study on East Asian breast cancers?\",\"answer\":\"To determine how age and ethnicity influence molecular properties and clinical disparities in East Asian breast cancer patients.\"},{\"question\":\"How were patients analyzed in this research?\",\"answer\":\"The study investigated 843 primary and metastatic patients from the K-MASTER program, stratifying them into two age subgroups, and compared findings with large-scale genomic data from TCGA and MSK-IMPACT.\"},{\"question\":\"Which molecular features were highlighted as differing across groups?\",\"answer\":\"The study reports a high prevalence of PI3KCA mutations in K-MASTER HER2+ tumors, particularly in older patients, and identifies increased mutation rates in DNA damage response genes including ARID1A, MSH6, and MLH1.\"}]","Age-and ethnic-driven molecular and clinical disparity of East Asian breast cancers | PDF",1790050683,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9a6026796dbbddb39daecab84cc900d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68de451cc508ae73627d93405e528da8.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a67f1ee205a3d877faa9ea026bc3f38.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e741a9516c74fdb5960184e73ac87066.webp",980,1301]